HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
HTL was pleased to share that Antoine Clavier-Choo, HTL head of Asia Pacific, participated in CPHI Japan, one of the largest pharmaceutical events in Asia.
The event was held on April 19-21, 2023, at the Tokyo Big Sight Exhibition Center.
CPHI Japan provided an excellent opportunity for us to network with industry experts, customers, and explore new partnerships and collaborations.
We were excited to learn about the latest trends and innovations in the pharmaceutical industry and share our knowledge and experience with others.
On October 28, 2025, HTL Biotechnology hosted its first-ever webinar, “Shaping the Future of Aesthetic Medicine with Premium Biopolymers,” a key initiative to strengthen our presence in Asia and promote the “Feel the Difference with HTL Inside” positioning among major players in aesthetic medicine.
This October, HTL Biotechnology turned pink to support breast cancer prevention.
HTL Biotechnology is the winner of the Responsible Care West Atlantic Trophy in the ‘Energy – Climate’ category for its project to reduce carbon emissions from distillation systems.